Of those regions assayed for enhancer activity, four were able to increase luciferase expression levels under the control of the SCL pro1a and/or SV40 promoters in either K562 or HPB-ALL (Figure 4a). The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.